Occlusive Venopathy Phenotype in Hereditary Pulmonary Arterial Hypertension

被引:1
作者
Franchi, Sonia Meiken [1 ]
Aiello, Vera D. [1 ]
Lopes, Antonio Augusto [1 ]
机构
[1] Univ Sao Paulo, Fac Med, Inst Coracao InCor, Sao Paulo, Brazil
关键词
Pulmonary hypertension; pulmonary occlusive venopathy; microvasculopathy; hereditary pulmonary arterial hypertension; sildenafil; PROSTACYCLIN; SILDENAFIL; PATIENT;
D O I
10.1590/S0066-782X2011000900019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 33-year-old male with severe hereditary pulmonary arterial hypertension had a confirmed diagnosis of occlusive venopathy and microvasculopathy. He remained stable for three and a half years on oral sildenafil, 75 mg t.i.d. (six-minute walked distance of 375 m vs 105 m at baseline), but required addition of bosentan (125 mg b.i.d.), subsequently. Despite the fatal outcome at five years post-diagnosis, the observations suggest a potential usefulness of vasodilators as a bridge for lung transplant in selected cases with significant venous/capillary involvement. The occurrence of veno-occlusive and capillary lesions in the familial form of pulmonary arterial hypertension reinforces the difficulties with the current classification of the disease.
引用
收藏
页码:E8 / E10
页数:3
相关论文
共 10 条
[1]   PRIMARY PULMONARY-HYPERTENSION - A HISTOPATHOLOGIC STUDY OF 80 CASES [J].
BJORNSSON, J ;
EDWARDS, WD .
MAYO CLINIC PROCEEDINGS, 1985, 60 (01) :16-25
[2]   Sildenafil citrate therapy for pulmonary arterial hypertension [J].
Galiè, N ;
Ghofrani, HA ;
Torbicki, A ;
Barst, RJ ;
Rubin, LJ ;
Badesch, D ;
Fleming, T ;
Parpia, T ;
Burgess, G ;
Branzi, A ;
Grimminger, F ;
Kurzyna, M ;
Simonneau, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (20) :2148-2157
[3]  
Galie N, 2006, NEW ENGL J MED, V354, P2400, DOI [DOI 10.1056/NEJMOA050010, 10.1056/NEJMoa050010]
[4]   BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension [J].
Machado, RD ;
Pauciulo, MW ;
Thomson, JR ;
Lane, KB ;
Morgan, NV ;
Wheeler, L ;
Phillips, JA ;
Newman, J ;
Williams, D ;
Galiè, N ;
Manes, A ;
McNeil, K ;
Yacoub, M ;
Mikhail, G ;
Rogers, P ;
Corris, P ;
Humbert, M ;
Donnai, D ;
Martensson, G ;
Tranebjaerg, L ;
Loyd, JE ;
Trembath, RC ;
Nichols, WC .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (01) :92-102
[5]   Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension - Comparison with inhaled nitric oxide [J].
Michelakis, E ;
Tymchak, W ;
Lien, D ;
Webster, L ;
Hashimoto, K ;
Archer, S .
CIRCULATION, 2002, 105 (20) :2398-2403
[6]   Effects of continuous IV prostacyclin in a patient with pulmonary veno-occlusive disease [J].
Okumura, H ;
Nagaya, N ;
Kyotani, S ;
Sakamaki, F ;
Nakanishi, N ;
Fukuhara, S ;
Yutani, C .
CHEST, 2002, 122 (03) :1096-1098
[7]   Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease [J].
Palmer, SM ;
Robinson, LJ ;
Wang, AD ;
Gossage, JR ;
Bashore, T ;
Tapson, SF .
CHEST, 1998, 113 (01) :237-240
[8]   Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II [J].
Runo, JR ;
Vnencak-Jones, CL ;
Prince, M ;
Loyd, JE ;
Wheeler, L ;
Robbins, IM ;
Lane, KB ;
Newman, JH ;
Johnson, J ;
Nichols, WC ;
Phillips, JA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (06) :889-894
[9]  
Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]
[10]   LUNG-BIOPSY SPECIMENS IN THE EVALUATION OF PULMONARY VASCULAR-DISEASE [J].
WAGENVOORT, CA .
CHEST, 1980, 77 (05) :614-625